<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
	<channel rdf:about="http://www.mdpi.com/rss/special_issue/phytochemicals">
		<title>Pharmaceuticals: Phytochemicals with actions on the Central Nervous System</title>
		<link>http://www.mdpi.com/journal/pharmaceuticals/special_issues/phytochemicals/</link>
		<description>Dear Colleagues,  The proposed special edition will focus on the positive effects of  plants and plant extracts that possess action on the central nervous  system (CNS). The effect of plant extracts as appetite regulators,  adaptogens, stimulants, hallucinogens, analgesics, anxiolytics,  antidepressants and neuroprotectors will be examined. The issue will  include anatomical and functional interactions and it is going to focus  in both behavioural as well as cellular mechanisms. The edition will  start with a brief comment on the field and review of the main areas of  research in which these interactions are under current investigation.  Where possible clinical as well as basic experimental science will be  included.   These chapter headings and content are designed to appeal to  the largest possible audience within this field (academic, industrial  and clinical), but also to prevent overlap and repetition  Sonia Tucci, Ph. D. Guest Editor  Submission Information
All papers should be submitted to pharmaceuticals@mdpi.com. To be published continuously until the deadline and papers will be listed together at the special issue website.
Submitted papers should not have been published nor be under consideration for publication elsewhere. All papers are refereed through a peer-review process. A guide for authors is available on the Instructions for Authors page. Pharmaceuticals is a new international, peer-reviewed, quarterly open access journal published by MDPI.
Article Processing Charges (APC) for publication in this open access journal are waived for well-prepared manuscripts submitted by 30 June 2010. English correction or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those paper accepted for publication, that require extensive additional formatting and/or English corrections.</description>
								<items>
			<rdf:Seq>
							<rdf:li rdf:resource="http://www.mdpi.com/1424-8247/3/7/2333/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1424-8247/3/3/748/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1424-8247/3/1/188/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1424-8247/2/3/194/" />
                    	</rdf:Seq>
		</items>
				<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
	</channel>
	<item rdf:about="http://www.mdpi.com/1424-8247/3/7/2333/">
	<title>Pharmaceuticals, Vol. 3, Pages 2333-2361: The Health Effect of Psychostimulants: A Literature Review</title>
	<link>http://www.mdpi.com/1424-8247/3/7/2333/</link>
	<description>Prevalence of psychostimulant use is high, and raising in several countries. Nicotine is the legal stimulant causing the most important public health impact. Cocaine ranks among the most used illicit substances after cannabis. Stimulant medications are frequently misused. Psychostimulants can lead to addiction, have physical, psychological and social health consequences and can induce a great disease burden. The aim of the present article is to provide a literature review on the health effects of stimulants as potential drugs of abuse. It will cover essentially cocaine, amphetamines and its derivatives (including methamphetamines and 3-4-methylenedioxymethamphetamine, ecstasy), nicotine, caffeine and khat, and touch upon the issues of prescribed substances (anti-depressants, weight control medications, attention-deficit hyperactivity disorder medications, hypersomniac disorder). Their pharmacology, addictive potential, health consequences and treatment will be discussed. We used Medline for the literature review from 1990 to the date of this review, and mention the findings of human and animal studies (the latter only if they are of clinical relevance).</description>
	
	<guid>http://www.mdpi.com/1424-8247/3/7/2333/</guid>
	<pubDate>Thu, 22 Jul 2010 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Pharmaceuticals</prism:publicationName>
	<prism:publicationDate>2010-07-22</prism:publicationDate>
	<prism:volume>3</prism:volume>
	<prism:number>7</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>2333</prism:startingPage>
		<prism:endingPage>2361</prism:endingPage>
		<prism:issn>1424-8247</prism:issn>
	
	<dc:title>The Health Effect of Psychostimulants: A Literature Review</dc:title>
	<dc:date>2010-07-22</dc:date>
	<dc:identifier>doi: 10.3390/ph3072333</dc:identifier>
		<dc:creator>Thierry Favrod-Coune</dc:creator>
		<dc:creator>Barbara Broers</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1424-8247/3/3/748/">
	<title>Pharmaceuticals, Vol. 3, Pages 748-763: Phytochemicals in the Control of Human Appetite and Body Weight</title>
	<link>http://www.mdpi.com/1424-8247/3/3/748/</link>
	<description>Since obesity has grown to epidemic proportions, its effective management is a very important clinical issue. Despite the great amount of scientific effort that has been put into understanding the mechanisms that lead to overconsumption and overweight, at the moment very few approaches to weight management are effective in the long term. On the other hand, modern society is also affected by the growing incidence of eating disorders on the other side of the spectrum such as anorexia and bulimia nervosa which are equally difficult to treat. This review will try to summarise the main findings available in the literature regarding the effect of plants or plant extracts (phytochemicals) on human appetite and body weight. The majority of plant extracts are not single compounds but rather a mixture of different molecules, therefore their mechanism of action usually targets several systems. In addition, since some cellular receptors tend to be widely distributed, sometimes a single molecule can have a widespread effect. This review will attempt to describe the main phytochemicals that have been suggested to affect the homeostatic mechanisms that influence intake and body weight. Clinical data will be summarised and scientific evidence will be reviewed.</description>
	
	<guid>http://www.mdpi.com/1424-8247/3/3/748/</guid>
	<pubDate>Mon, 22 Mar 2010 00:00:00 CET</pubDate>
	
	<prism:publicationName>Pharmaceuticals</prism:publicationName>
	<prism:publicationDate>2010-03-22</prism:publicationDate>
	<prism:volume>3</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>748</prism:startingPage>
		<prism:endingPage>763</prism:endingPage>
		<prism:issn>1424-8247</prism:issn>
	
	<dc:title>Phytochemicals in the Control of Human Appetite and Body Weight</dc:title>
	<dc:date>2010-03-22</dc:date>
	<dc:identifier>doi: 10.3390/ph3030748</dc:identifier>
		<dc:creator> Tucci</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1424-8247/3/1/188/">
	<title>Pharmaceuticals, Vol. 3, Pages 188-224: Effects of Adaptogens on the Central Nervous System and the Molecular Mechanisms Associated with Their Stress—Protective Activity</title>
	<link>http://www.mdpi.com/1424-8247/3/1/188/</link>
	<description>Adaptogens were initially defined as substances that enhance the “state of nonspecific resistance” in stress, a physiological condition that is linked with various disorders of the neuroendocrine-immune system. Studies on animals and isolated neuronal cells have revealed that adaptogens exhibit neuroprotective, anti-fatigue, antidepressive, anxiolytic, nootropic and CNS stimulating activity. In addition, a number of clinical trials demonstrate that adaptogens exert an anti-fatigue effect that increases mental work capacity against a background of stress and fatigue, particularly in tolerance to mental exhaustion and enhanced attention. Indeed, recent pharmacological studies of a number of adaptogens have provided a rationale for these effects also at the molecular level. It was discovered that the stress—protective activity of adaptogens was associated with regulation of homeostasis via several mechanisms of action, which was linked with the hypothalamic-pituitary-adrenal axis and the regulation of key mediators of stress response, such as molecular chaperons (e.g., HSP70), stress-activated c-Jun N-terminal protein kinase 1 (JNK1), Forkhead box O (FOXO) transcription factor DAF-16, cortisol and nitric oxide.</description>
	
	<guid>http://www.mdpi.com/1424-8247/3/1/188/</guid>
	<pubDate>Tue, 19 Jan 2010 00:00:00 CET</pubDate>
	
	<prism:publicationName>Pharmaceuticals</prism:publicationName>
	<prism:publicationDate>2010-01-19</prism:publicationDate>
	<prism:volume>3</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>188</prism:startingPage>
		<prism:endingPage>224</prism:endingPage>
		<prism:issn>1424-8247</prism:issn>
	
	<dc:title>Effects of Adaptogens on the Central Nervous System and the Molecular Mechanisms Associated with Their Stress—Protective Activity</dc:title>
	<dc:date>2010-01-19</dc:date>
	<dc:identifier>doi: 10.3390/ph3010188</dc:identifier>
		<dc:creator>Alexander Panossian</dc:creator>
		<dc:creator>Georg Wikman</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1424-8247/2/3/194/">
	<title>Pharmaceuticals, Vol. 2, Pages 194-205: Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases</title>
	<link>http://www.mdpi.com/1424-8247/2/3/194/</link>
	<description>The prevention of aging is one of the most fascinating areas in biomedicine. The first step in the development of effective drugs for aging prevention is a knowledge of the biochemical pathways responsible for the cellular aging process. In this context it seems clear that free radicals play a key role in the aging process. However, in recent years it has been demonstrated that the families of enzymes called sirtuins, specifically situin 1 (SIRT1), have an anti-aging action. Thus, the natural compound resveratrol is a natural compound that shows a very strong activation of SIRT1 and also shows antioxidant effects. By activating sirtuin 1, resveratrol modulates the activity of numerous proteins, including peroxisome proliferator-activated receptor coactivator-1α (PGC-1 alpha), the FOXO family, Akt (protein kinase B) and NFκβ. In the present review, we suggest that resveratrol may constitute a potential drug for prevention of ageing and for the treatment of several diseases due to its antioxidant properties and sirtuin activation.</description>
	
	<guid>http://www.mdpi.com/1424-8247/2/3/194/</guid>
	<pubDate>Tue, 15 Dec 2009 00:00:00 CET</pubDate>
	
	<prism:publicationName>Pharmaceuticals</prism:publicationName>
	<prism:publicationDate>2009-12-15</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Review</prism:section>
	<prism:startingPage>194</prism:startingPage>
		<prism:endingPage>205</prism:endingPage>
		<prism:issn>1424-8247</prism:issn>
	
	<dc:title>Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases</dc:title>
	<dc:date>2009-12-15</dc:date>
	<dc:identifier>doi: 10.3390/ph2030194</dc:identifier>
		<dc:creator>Antoni Camins</dc:creator>
		<dc:creator>Felix Junyent</dc:creator>
		<dc:creator>Ester Verdaguer</dc:creator>
		<dc:creator>Carlos Beas-Zarate</dc:creator>
		<dc:creator>Argelia E. Rojas-Mayorquín</dc:creator>
		<dc:creator>Daniel Ortuño-Sahagún</dc:creator>
		<dc:creator>Mercè Pallàs</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>


<cc:License rdf:about="http://creativecommons.org/licenses/by/3.0/">
	<cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
	<cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
	<cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
</cc:License>

</rdf:RDF>
